Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2 Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 46 Paclitaxel 46 Gemcitabine 41 Carboplatin 37 Docetaxel 35 Bevacizumab 27 Cisplatin 25 Irinotecan 22 Nivolumab 20 Fluorouracil 20 Erlotinib Hydrochloride 18 Pemetrexed 17 Capecitabine 17 Sorafenib 16 Magnetic Resonance Spectroscopy 16 Cetuximab 16 Afatinib 16 Leucovorin 15 regorafenib 14 olaparib 13 Specimen Handling 13 Oxaliplatin 13 trametinib 12 Biopsy 12 130-nm albumin-bound paclitaxel 11 eribulin 10 atezolizumab 10 epothilone B 9 Radiotherapy 9 Midazolam 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × AEG 35156 × Tumor-Agnostic × Clear all

NCT00385775 2008-08-21

Study of XIAP Antisense for Advanced Cancers

Aegera Therapeutics

Phase 1 Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡